Showing 1761-1770 of 9101 results for "".
Medical Dermatology Myths
https://practicaldermatology.com/topics/general-topics/medical-dermatology-myths/22036/Here are the facts about seven common misconceptions that may hinder effective patient care.Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/issues/novemberdecember-2025/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/48890/Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.From Training to Transformation: How Leaders Get the Most Out of Educating Their Team
https://practicaldermatology.com/issues/september-2025/from-training-to-transformation-how-leaders-get-the-most-out-of-educating-their-team/37640/Imagine investing thousands of dollars in staff time and tuition for the latest aesthetic techniques or business courses—sending employees to conferences or bringing in an expert for in-office training—only to watch those skills fade, or be underused or forgotten.Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.An Exciting Integration of Two Cosmetic Conferences
https://practicaldermatology.com/topics/editorial/exciting-integration-two-cosmetic-conferences/28865/After 13 years of running Cosmetic Surgery Forum on my own, I am excited to announce the integration of Cosmetic Surgery Forum into the Multispecialty Aesthetic Conference (MAC), to be held in Hilton Head from March 27-30, 2025 at the oceanfront Westin Hilton Head Island Resort.Embrace Your Curiosity: The Power of Questions
https://practicaldermatology.com/topics/practice-management/embrace-your-curiosity-the-power-of-questions/24031/Asking empowering questions may yield more creative answers.Fighting for Change
https://practicaldermatology.com/topics/practice-management/fighting-for-change/23775/Unpacking the new AMA Recovery Plan for America’s physicians.Protect Yourself and Your Family with Effective Estate Planning
https://practicaldermatology.com/topics/practice-management/protect-yourself-and-your-family-with-effective-estate-planning/23727/Estate planning is an essential part of preserving and distributing your assets in the future.